Choose Language
Select a language for news translation.
A new kind of flu vaccine made with mRNA technology will soon be available. Marco Bello/Bloomberg/Getty Images hide caption For the latest stories on the scie…
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
In a first, U.S. approves powerful new mRNA vaccine for flu The flu shot, mFlusiva, was shown in a clinical trial to be up to 27 percent more effective than a…
A younger and higher-educated base were pivotal to Abdul El Sayed’s Senate Primary win, an analysis shows.
The Food and Drug Administration (FDA) late Wednesday approved the nation’s first mRNA flu vaccine, manufactured by drugmaker Moderna. The agency approved the …
In the Democratic Republic of the Congo, the Ebola outbreak is spreading, with the number of infections rising rapidly. Declared in mid-May, this seventeenth E…
The mFlusiva vaccine will soon be available for adults aged 50 and over. After initially refusing to even review it, the US Food and Drug Administration (FDA)…
The Food and Drug Administration on Wednesday approved the U.S.’s first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna.
UK scientists have developed a new dry powder vaccine that does not require refrigeration, potentially reducing the 50% vaccine waste caused by cold chain fail…
The Food and Drug Administration is expected to decide whether to approve the first mRNA flu vaccine.
But CEO Josh D’Amaro makes a case as for why the Star Wars movie was still successful as a portfolio booster.
